The Respiratory Drug Delivery section in Frontiers in Drug Delivery publishes high-quality fundamental and applied research across all aspects of respiratory drug delivery including the design and development of inhalation products, delivery of those products to the respiratory tract, and the evaluation of the performance of those products in vitro, in vivo and in human clinical studies.Read More
The Respiratory Drug Delivery section in Frontiers in Drug Delivery publishes high-quality fundamental and applied research across all aspects of respiratory drug delivery including the design and development of inhalation products, delivery of those products to the respiratory tract, and the evaluation of the performance of those products in vitro, in vivo and in human clinical studies. These combination products require an interdisciplinary team of scientists and engineers working in concert to gain approval for patient use. The Respiratory Drug Delivery section thus solicits significant advances in areas across these multidisciplinary fields including, but not limited to:
Characterizing and overcoming biological mechanisms and barriers in the lung
Development and characterization of in vitro and in vivo models of aerosol deposition, including impact of cough, lung injury or disease
Toxicology evaluation of inhaled products
Formulation of inhaled products including solutions, suspensions, powders, nanoparticles, microparticles
Inhaled device development including nebulizers, MDIs, DPIs, and soft mist inhalers
Human factors and performance characterization of inhaled products
Analytical tests and methodology for inhaled products including delivered dose, aerosol particle size distribution, particle characteristics and dissolution characteristics
Kinetics and modelling of drug release or clearance
Advanced imaging techniques characterizing lung disease or impact of treatments
Assessing and predicting in vitro - in vivo relationships for inhaled drug products
Clinical safety and efficacy studies of inhaled products
Regulatory requirements and development of bioequivalent inhaled products
All studies must contribute insights into respiratory drug delivery. Reports dealing with the pharmacology of drugs should be submitted to more specialized journals such as our sister journal, Frontiers in Pharmacology.
Indexed in: CLOCKSS, CrossRef, Google Scholar, OpenAIRE
Respiratory Drug Delivery welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Respiratory Drug Delivery, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com